Axim Biotechnologies Inc (AXIM)

$0.01 +0.00 (21.00%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 302,600
Avg Vol 319,310
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 98%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopharmaceutical research,...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 923 4422
Address:
6191 Cornerstone Court, East, Suite 114, San Diego, United States
khartinvest
khartinvest Nov. 12 at 9:18 PM
$AXIM $MJNA Another 52 week high for AXIM...
0 · Reply
khartinvest
khartinvest Nov. 12 at 12:31 AM
$AXIM High volume today...
1 · Reply
barry9
barry9 Nov. 6 at 10:26 PM
$AXIM if there was ever a time to hold and pray.
1 · Reply
Inittowinits
Inittowinits Nov. 3 at 8:29 PM
$AXIM
2 · Reply
Inittowinits
Inittowinits Oct. 31 at 8:22 PM
$AXIM 👀 happy not a fraction day
1 · Reply
TexasMarvL
TexasMarvL Oct. 28 at 2:50 AM
$AXIM Up 91% in last month.
0 · Reply
khartinvest
khartinvest Oct. 23 at 12:31 PM
$AXIM another agreement... https://aximbiotech.com/axim-biotechnologies-inc-announces-exclusive-distribution-agreement-with-visionplus-corp-for-tearscan-lactoferrin-and-ige-diagnostic-tests-in-south-korea/
1 · Reply
khartinvest
khartinvest Oct. 21 at 9:37 PM
$AXIM Could just be an end of day thing but yet super interesting and not finding any news but ask 30 minutes ago was .014 and just went to .05 - not typical.
0 · Reply
khartinvest
khartinvest Oct. 17 at 9:01 PM
$AXIM AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests
1 · Reply
khartinvest
khartinvest Oct. 17 at 8:43 PM
$AXIM https://www.otcmarkets.com/stock/AXIM/news/AXIM-Biotechnologies-Announces-Exclusive-Latin-America-License--Distribution-Agreement-With-JK-Medical-for-TearScanR-Ocu?id=495040
0 · Reply
Latest News on AXIM
No data available.
khartinvest
khartinvest Nov. 12 at 9:18 PM
$AXIM $MJNA Another 52 week high for AXIM...
0 · Reply
khartinvest
khartinvest Nov. 12 at 12:31 AM
$AXIM High volume today...
1 · Reply
barry9
barry9 Nov. 6 at 10:26 PM
$AXIM if there was ever a time to hold and pray.
1 · Reply
Inittowinits
Inittowinits Nov. 3 at 8:29 PM
$AXIM
2 · Reply
Inittowinits
Inittowinits Oct. 31 at 8:22 PM
$AXIM 👀 happy not a fraction day
1 · Reply
TexasMarvL
TexasMarvL Oct. 28 at 2:50 AM
$AXIM Up 91% in last month.
0 · Reply
khartinvest
khartinvest Oct. 23 at 12:31 PM
$AXIM another agreement... https://aximbiotech.com/axim-biotechnologies-inc-announces-exclusive-distribution-agreement-with-visionplus-corp-for-tearscan-lactoferrin-and-ige-diagnostic-tests-in-south-korea/
1 · Reply
khartinvest
khartinvest Oct. 21 at 9:37 PM
$AXIM Could just be an end of day thing but yet super interesting and not finding any news but ask 30 minutes ago was .014 and just went to .05 - not typical.
0 · Reply
khartinvest
khartinvest Oct. 17 at 9:01 PM
$AXIM AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests
1 · Reply
khartinvest
khartinvest Oct. 17 at 8:43 PM
$AXIM https://www.otcmarkets.com/stock/AXIM/news/AXIM-Biotechnologies-Announces-Exclusive-Latin-America-License--Distribution-Agreement-With-JK-Medical-for-TearScanR-Ocu?id=495040
0 · Reply
TexasMarvL
TexasMarvL Oct. 9 at 8:56 PM
$AXIM What's going on here?
3 · Reply
DinoTradez
DinoTradez Oct. 2 at 5:42 PM
$AXIM Good morning people!
1 · Reply
javanz
javanz Jul. 10 at 2:11 PM
$AXIM why’d all the lame players here keep such a Great Potential in flux?
1 · Reply
javanz
javanz Jul. 4 at 3:00 PM
$AXIM https://www.earth.com/news/your-eyes-vision-could-alert-you-to-dementia-alzheimers-disease-up-to-12-years-earlier/
0 · Reply
Inittowinits
Inittowinits Jul. 1 at 8:14 AM
$AXIM 75-90 days and this just a hey what do you need us to do request before actual submission. But hey, it’s the first signs of life in a really long time. I think they should also reengage the COVID test through the fda.
1 · Reply
khartinvest
khartinvest Jun. 30 at 2:22 PM
$AXIM https://aximbiotech.com/axim-biotechnologies-files-pre-submission-with-fda-for-clia-waiver-pathway-on-lactoferrin-point-of-care-diagnostic-test/
1 · Reply
TexasMarvL
TexasMarvL Mar. 9 at 7:35 PM
$AXIM Just to clarify. I am no longer an investor here. I still follow AXIM out of curiosity. The AXIM Website still exists and has been updated to show the new leadership structure. I will also mention that the Versea Ophthalmics web page no longer mentions T-POC. My assumption is the relationship with Verséa has been terminated. Last I checked AXIM is behind on SEC Filings. https://aximbiotech.com/about/
1 · Reply
javanz
javanz Jan. 25 at 3:15 PM
$AXIM Super Fast: https://scitechdaily.com/light-speed-imaging-a-breakthrough-in-edge-detection/
0 · Reply
javanz
javanz Jan. 25 at 2:42 PM
$AXIM Next Generation: http://opr.news/57cd55ce250123en_us?link=1&client=iosnews
0 · Reply
barry9
barry9 Jan. 22 at 8:16 PM
$AXIM ok
1 · Reply
UCIdidmyDD
UCIdidmyDD Dec. 20 at 9:42 AM
$AXIM another useless board of directors who overpaid a dud ceo. he took the companys assets and of course the lowly shareholders as well mjna gets a nice write off they can never use
0 · Reply
TexasMarvL
TexasMarvL Dec. 13 at 12:48 PM
$AXIM AXIM filed a Form 15. Currently links to TPOC are disabled on the Verséa Ophthalmics website. However, a Video posted yesterday on LinkedIn. It sounds like Verséa Ophthalmics is still talking about their TPOC diagnostic tests. https://www.linkedin.com/posts/ophthopedia_video-vers%C3%A9a-focused-on-diagnostic-technologies-activity-7273073162051805185-pY4-?utm_source=share&utm_medium=member_android I'm not familiar with the rules and laws surrounding bankruptcy and the rights to the company's assets. However this video seems to imply Verséa Ophthalmics will still market the tests. I wonder if a new Sapphire Biotech will rise out of the ashes of the AXIM failures? The IP portfolio still has value even after AXIM goes through bankruptcy.
0 · Reply